FTC Tells Justices To Nix Sham Litigation Exception Case
The Federal Trade Commission has urged the U.S. Supreme Court not to review a Third Circuit ruling that AbbVie delayed generic versions of its testosterone treatment AndroGel through sham litigation....To view the full article, register now.
Already a subscriber? Click here to view full article